NCT00148785View on ClinicalTrials.gov

A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

January 31, 2007

Conditions
HIV Infections
Interventions
DRUG

Indinavir/Ritonavir/Fosamprenavir

Trial Locations (1)

30308

Grady Infectious Diseases Program, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT00148785 - A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir | Biotech Hunter | Biotech Hunter